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Background: Hepatitis B is the most common chronic viral infection in humans and the 
most common cause of death among viral hepatitis. As 70% to 80% of chronic hepatitis 
cases are caused by HBV in Iran, this virus alone is considered the most important cause 
of liver diseases and the major cause of mortality arising from viral hepatitis cases in 
Iran.
Objectives: We planned this study to determine the prevalence of hepatitis B in the gen-
eral population of Qom, central Iran. 
Patients and Methods: The present study is a cross-sectional study. A total of 3690 sam-
ples were collected from 7 rural clusters and 116 urban clusters. Ten teams, each consist-
ing of 2 trained members, were assigned to conduct the sampling and fill the question-
naires. The data were analyzed using SPSS.
Results: The prevalence rate of hepatitis B infection in Qom Province was 1.3%. The mean 
age of the patients with hepatitis B was 44.17 years. The prevalence of hepatitis B was 1.6% 
in men and 1.1% in women. Moreover, the prevalence of hepatitis B correlated positively 
with age, tattooing, and literacy level.
Conclusions: The prevalence rate of hepatitis B in Qom is 1.3%. It is possible to prevent the 
disease by increasing public awareness. Further investigation on clinical presentations 
and a determination of the genotype of the virus are suggested.
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 Implication for health policy/practice/research/medical education:
Due to major doubts in understanding the best strategy for differentiating between HBeAg negative and inactive carriers, this 
diagnostic study is recommended to all clinicians involved in treatment of patients with HBV infection. 
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1. Background
Hepatitis B is the most common chronic viral infec-
tion in humans. HBV infection is one of the major pub-
lic health problems throughout the world. Nearly 350 to 
400 million people suffer from this infection globally, 
and 1 million people per year lose their lives due to com-113
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plications of this infection (1). On the other hand, hepa-
titis is the major cause of hepatic cirrhosis and hepato-
cellular carcinoma. It is believed that the most common 
cause of liver cancers is viral infection. The prevalence of 
hepatitis B carriers in different parts of the world varies 
from 0.5% to > 8%. Since most children and adults suffer-
ing from this virus do not have clinical symptoms, se-
roepidemiological studies provide a broader picture of 
the distribution of the infection. Determining the trend 
of HBV infection is important in assessing the efficiency 
of vaccination in infants and young adults (2-4). In the 
studies that have been conducted in Iran, the average 
rate of HBV infection has always been 3%. In these stud-
ies, the rate of HBV prevalence in blood donors is 3.4%, 
ranging from 1.7% in Fars Province to over 5% in Sistan-
Baluchestan Province (2, 3). This difference has also been 
seen in recent studies, in which the HBV prevalence rate 
in 2003 was 0.5% in blood donors and students (5, 6) and 
6% in large vehicle drivers (7). In a study conducted by 
the Gastroenterological and Liver Diseases Research Cen-
ter of Tehran University in Gonbad, northeastern Iran, 
the prevalence of HBV in normal inhabitants of the city 
was reported to be 4.5%—1.5 times the average rate (8). 
The high prevalence rate shows that despite the 35-year 
history of studies on this disease in Iran and despite the 
nationwide immunization of newborns, infection with 
this virus is still considered a major health problem in 
Iran, and the risk of severe complications poses a threat 
to many individuals in the community. 
2. Objectives
Since the studies in Iran have been based on serological 
tests on individuals visiting health centers and blood do-
nors—not on normal individuals in the community—be-
cause the policies of the Blood Transfusion Organization 
(BTO) for selecting blood donors have been changed in 
recent years, and because the figures of 3% (3) and 5% (5) 
obtained in recent studies conducted by the BTO cannot 
show the actual prevalence rate of the infection in the 
community, the present study aimed to determine the 
prevalence rate and risk factors of HBV infection in Qom, 
central Iran. 
2. Patients and Methods
The present study is a cross-sectional study. A popula-
tion of 3690 individuals was assigned to the study by 
cluster sampling. Seven rural clusters and 116 urban clus-
ters were selected, based on girls’ elementary schools in 
different districts of the province. For sampling purpos-
es, only one person from each family was selected ran-
domly by draw of the lots. Then, the phases of the study 
were explained to the individuals who were eligible for 
the study. Those who were interested were invited to 
undergo tests and complete the questionnaires. A ques-
tionnaire, including such data as age, sex, marital status, 
occupation, literacy level, blood transfusion history, his-
tory of surgery, dental surgery, viral hepatitis, immuni-
zation, narcotic drug consumption, smoking, tattooing, 
cupping, endoscopy, and AIDS, was completed for each 
participant. Ten teams consisted of two trained mem-
bers who were responsible for preparing samples and 
completing the questionnaires. Nearly 5 cc of serum was 
taken from each subject and transferred to the lab under 
sterile conditions in ice bags. HBs antigen was measured 
by ELISA. All patients gave written informed consent, and 
the study protocol was approved by the ethics commit-
tee of Qom University of Medical Sciences. Quantitative 
variables were analyzed by t test and Mann-Whitney 
test. Categorical variables were analyzed by Pearson chi-
square test and Fisher exact test. Multivariate analysis 
was performed to adjust for potential confounders. Sta-
tistical analysis was performed using SPSS®. P < 0.05 was 
considered significant 
3. Results
Out of 3690 subjects, 48 (1.3%) suffered from hepatitis 
B, and 46.6% of subjects were male and 54.4% was female 
(Table 1); 129 (3.5%) subjects had a history of immuniza-
tion, and none had hepatitis B. Further, 1.3% of subjects 
without an immunization history suffered from hepati-
tis B. The occupational distribution of the participants is 
presented in Table 2. In this study, the mean age of sub-
jects with hepatitis B was 44.17 years, with a standard 
deviation of 15.75 years; the mean age of those who did 
not suffer from hepatitis B was 36.45 years, with a stan-
dard deviation of 14.42 years, which, by Kolmogorov test, 
showed a significant difference from normal distribu-
tion. Mann-Whitney test was used to investigate the re-
lationship between age and hepatitis B infection. As a re-
sult, the age of the subjects with and without hepatitis B 
infection differed significantly (P = 0.001). Therefore, we 
concluded that the mean age of individuals with hepati-
tis was significantly higher than those who did not suffer 
from the disease. Of all samples, 0.7% (26 subjects) had a 
history of viral hepatitis, 7.7% of whom had suffered from 
hepatitis B. Of 48 subjects with hepatitis B, 47 answered 
this question, 4.3% of whom had a history of viral hepati-
tis, and of 3444 subjects without hepatitis, 7% had a his-
tory of hepatitis B. In this study, the prevalence of smok-
ing in Qom Province was 9% (those who had a history of 
smoking at least 1 month prior to the study were consid-
ered smokers). The prevalence of hepatitis B infection 
was 2.2% in smokers versus 1.2% in nonsmokers. Two per-
cent of the statistical population in this study had rarely 
used alcohol, and 4.3% of individuals with hepatitis B in 
Qom Province had rarely used alcohol. The prevalence 
of hepatitis B in such individuals was 2.7%, versus 1.3% in 
those who had never used alcohol. By chi-square test (P = 
0.008), there was a significant relationship between tat-
tooing and hepatitis B infection. The prevalence of HBV 
infection by occupation of the participants is presented 
in Table 2. By chi-square test, there was a significant rela-
tionship between the level of education and hepatitis B 
(P = 0.019). Among the subjects, 0.4% had AIDS, none of 
whom had hepatitis B infection. The Fisher test showed 114
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Total Population, No. (%) HBsAg Positive, No. (%) HBsAg Negative, No. (%)
Sex
Male
Female
1709 (46.62)
1957 (53.38)
27 (1.58)
21 (1.07)
1682 (98.42)
1936 (98.93)
History of hepatitis
Yes
No
47 (1.35)
3444 (98.65)
23 (48.94)
45 (1.31)
24 (51.06)
3420 (99.30)
Drug addiction
Yes
Occasionally
No
67 (1.87)
20 (0.56)
3498 (97.57)
0 (0.00)
2 (10.00)
44 (1.26)
67 (100.00)
18 (90.00)
3454 (98.74)
Smoking
Yes
No
325 (9.01)
3282 (90.99)
7 (2.15)
41 (1.25)
318 (97.85)
3241 (98.75)
Tattooing
Yes
No
166 (4.54)
3490 (95.46)
6 (3.61)
42 (1.20)
160 (96.39)
3448 (98.80)
Marital status
Single
Married
Divorced
Widowed
677 (19.09)
2741 (77.28)
16 (0.45)
113 (3.19)
6 (0.89)
38 (1.39)
1 (6.25)
2 (1.77)
671 (99.11)
2703 (98.61)
15 (93.75)
111 (98.23)
Education
None
Writing and reading
Primary
Middle
High school
Academic
Seminary
474 (12.96)
231 (6.32)
690 (18.87)
661 (18.08)
942 (25.77)
507 (13.87)
151 (4.13)
14 (2.95)
3 (1.30)
11 (1.59)
7 (1.06)
6 (0.64)
5 (0.99)
1 (0.66)
460 (97.05)
228 (98.70)
679 (98.41)
654 (98.94)
936 (99.36)
502 (99.01)
150 (99.34)
Transfusion history
Yes
No
123 (3.40)
3498 (96.60)
2 (1.63)
45 (1.29)
121 (98.37)
3453 (98.71)
Dialysis history
Yes
No
11 (0.31)
3568 (99.69)
0 (0.00)
47 (1.32)
11 (100.00)
3521 (98.68)
Surgery history
Yes
No
114 (3.21)
3441 (96.79)
1 (0.88)
45 (1.31)
113 (99.12)
3396 (98.69)
Cupping history
Yes
No
795 (21.73)
2863 (78.27)
6 (0.75)
42 (1.47)
789 (99.25)
2821 (98.53)
Dental procedure history
Yes
No
2238 (60.85)
1440 (39.15)
29 (1.30)
19 (1.32)
2209 (98.70)
1421 (98.68)
Endoscopic history
Yes
No
281 (7.64)
3396 (92.36)
7 (2.49)
41 (1.21)
274 (97.51)
3355 (98.79)
Table 1. Seoprevalence of HBs Antigen According to Demographic Characteristics in Qom115
Distribution and Risk Factors of Hepatitis B Virus Infection Ghadir MR
Hepat Mon. 2012;12(2):112-117
no significant difference (P = 1.000). Multivariate logistic 
regression was performed to adjust for potential con-
founders, and the results are presented in Table 3.
4. Discussion
Despite the availability of an effective vaccine and the 
progress that has been made in antiviral treatments, 
hepatitis B continues to be a major public health prob-
lem in the world (9). The present study found that the 
prevalence of hepatitis B in the Qom Province is 1.3%. The 
studies conducted by Ataei et al. in Esfahan, Iran, and 
Kazerani in Kermanshah, Iran, also observed a rate of 
1.3%, which confirms the results of our study (10, 11). In a 
study by Alavian et al. the prevalence of hepatitis B in Iran 
was 2.14%. In this study, the geographical distribution of 
hepatitis B in Iran was heterogeneous, indicative of the 
difference between likely risk factors in different parts 
of Iran (12). The prevalence of hepatitis B is 0.5% to 0.8% 
in Australia (13) and 10% to 19.5% in Vietnam (14, 15). The 
difference in the prevalence of hepatitis B between differ-
ent countries is probably indicative of the disparate rates 
of contact with risk factors. In this study, the prevalence 
of hepatitis B in males and females was 1.6% and 1.1%, re-
spectively. In the studies by Alizadeh et al. in Hamedan 
Province, Iran, and Meraat et al. in Hormozgan Province, 
Iran, the prevalence in males was higher than in females, 
which confirms the results of our study (16). The higher 
rate of hepatitis B prevalence in males than females is 
likely due to the higher exposure to occupational HBV 
risk factors in men in Iran. In several studies in Iran, fe-
males had a higher prevalence (17), and in others, the 
prevalence in males and females was equal (18, 19).
In our study, the mean age of patients with hepatitis B 
infection was 44.17 years. In the study by Qureshi et al. in 
Total Subjects, % HBV Infection Prevalence, %
School-goers 5.3 0
University students 5.1 0.5
Homemakers 46.3 1
Farmers 1.3 2.1
Employees 8.1 1
Clerics 4.2 0.6
Self-employed 17.8 2
Prisoners 3.5 3
Soldiers 0.2 0
Unemployed 2.6 2.1
Workers 5.2 0
Other jobs 0.2 0
 
Table 2. Prevalence of HBV Infection According to Occupation of the Participants in Qom
                                                           HBsAg Positive
P value Statistically Significant
Sex 0.178 No
Age 0.001 Yes
History of hepatitis 0.047 No
Smoking 0.175 No
Tattooing 0.008 Yes
Marital status 0.023 Yes
Education 0.019 Yes
Transfusion history 0.744 No
Dialysis history 1 No
Surgery history 0.6 No
Cupping history 0.118 No
Dental procedure history 0.951 No
Endoscopic history 0.68 No
Table 3. Multivariate Logistic Regression of Possible Risk Factors For Hbs Antigen116
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Pakistan, the highest rate of hepatitis B correlated with 
age above 50 years (20). In the study by Zali et al. the high-
est prevalence also occurred in the 50-59-year age group 
(21). However, in the study by Abdollahi et al., the high-
est prevalence in Golestan Province was observed in the 
25-34-year age group (22). In the present study, 1.9% of 
the subjects had a history of taking narcotics, of which 
21.4% were intravenous users. The prevalence of HBV in 
individuals who took narcotics occasionally was higher 
than those who had no history. In the study by Qureshi 
et al., the highest prevalence was in the group who had a 
history of over 10 injections, and as the number of injec-
tions increased, so did the rate of HBV (20). In this study, 
the prevalence of HBV was higher in divorced individu-
als. There was a significant relationship between HBV 
prevalence and marital status (P = 0.023). In the study by 
Abdollahi et al. the rate of HBV was higher in singles than 
those who had married at least once (22). In the study by 
Zali et al. marital status was also a key indicator of preva-
lence (21). In many studies, marriage and heterosexual 
relationships are considered risk factors for HBV (23-25). 
Such differences are probably due to cultural differences 
in each community. In a study by McQuillan et al. in the 
US, the HBV was higher in widows than others (26).
In this study, the prevalence of HBV in illiterates was 
higher than in others, and there was a significant rela-
tionship between literacy level (education) and hepatitis 
B. In a study by McQuillan et al. the highest rate of HBV 
was in literates with below-high-school qualifications, 
and HBV prevalence fell with rises in literacy level, which 
corresponds to the results of our study (26). In the pres-
ent study, the prevalence of HBV was lower in individuals 
with a history of surgery than those who did not have a 
history, whereas in the study by Qureshi et al. in Pakistan, 
the rate of HBV in individuals with a history of surgery 
was higher (20). This is probably indicative of better 
postoperative care in Iran. In a study by Zali et al. a his-
tory of major surgery was a risk factor for HBV (21).
The prevalence of HBV in individuals with a history of 
tattooing was significantly higher than those without 
a history. In a study by Zhang et al. in Canada, tattooing 
did not increase the risk of hepatitis significantly (27). 
In a study by Qureshi et al. in Pakistan, the prevalence of 
HBV in individuals with a history of tattooing was not 
significantly higher than those without a history of tat-
tooing (20). This difference might be due to the effect of 
the confounding variable in our study. In most studies in 
Iran, a history of blood transfusion has not been a ma-
jor risk factor, which corresponds to our study, whereas 
other factors, such as sexual relationship, injections, 
imprisonment, driving, and non-sterile actions, such as 
tattooing, play a more important role in communicating 
hepatitis B (28). The study by Zali et al. considered such 
risk factors as old age, masculinity, marital status, histo-
ry of contact with hepatitis, sexual activity, intravenous 
drug use, major surgeries, visiting unqualified dentists, 
and certain occupations (29). Despite the fact that there 
is no effective treatment available that can, in the case 
of early diagnosis, inhibit the trend of the acute disease, 
some treatment procedures can stop the liver deteriora-
tion and prevent the incidence of hepatic cirrhosis and 
hepatocellular carcinoma. Therefore, faster identifica-
tion of chronic cases without clinical symptoms, which 
can be done by taking a history, conducting serological 
tests, measuring hepatic enzymes, measuring viral load, 
performing ultrasound sonography, and determining 
the risk factors that lead to the disease in the region, can 
help officials and authorities adopt proper measures to 
identify the virus-transmitting factors in the community 
with the aim of cutting the transmission chain. 
The fate of chronic hepatitis B disease from the carrier 
who has no symptoms to the emergence of compensated 
or decompensated cirrhosis and/or hepatocellular carci-
noma and, ultimately, death can vary. The emergence of 
the complications of the disease can lead to long periods 
of hospitalization, consumption of expensive medica-
tions, and ultimately liver transplantation, which impos-
es heavy costs on the government and the community. 
Thus, the virus-transmitting factors in the community 
and the chronic carriers of the virus must be identified 
all countries, which has been considered in other devel-
oping countries. The limitation of our study was that 
we did not measure the serum levels of HBc antigen in 
participants of this study; thus, our results may be un-
derestimated. Based on this study, the prevalence rate 
of hepatitis B in Qom Province, Iran, was 1.3%. Further in-
vestigations on the clinical presentations and genotype 
of the virus are recommended. Since this study was con-
ducted for the first time in the region, the results should 
provide officials with new and comprehensive data on 
the characteristics of the disease in the region, allowing 
them to make proper plans and adopt appropriate strat-
egies in preventing, treating, and immunizing patients.
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